Evaluation of prognostic nutritional status and lipid profile in gestational diabetes
, 1, 1, 1, 1, 1, 1, 1, 2, 1
Abstract
Objectives: This study aimed to investigate the relationship between controlling nutritional status index (CONUT) and prognostic nutrition index (PNI) scores that are used to evaluate nutritional status and GDM. Also, lipid abnormalities and albumin levels in pregnant women with normal glucose tolerance and GDM were researched. Material and methods: This study was conducted as a retrospective study at Ankara Etlik City Hospital, Turkey. The study included 67 pregnant women with singleton pregnancies (32 pregnant diagnosed with GDM and 35 pregnant known to be normoglycemic). Results: There were no statistical differences between the groups in terms of maternal age, gravidity, parity, history of miscarriage and weight gain during pregnancy. Body mass index (BMI) was higher in the GDM group (p = 0.001). There was no difference in the CONUT score between the groups (p = 0.254). The PNI score was lower in the GDM group (p = 0.003). Of the laboratory data, only fasting blood glucose, triglycerides (TG) and total cholesterol (TC) were statistically significantly higher, and albumin was lower in the GDM group (p = 0.026, p = 0.007, p = 0.003 and p = 0.003, respectively). Conclusions: PNI has the potential to be a useful predictor of GDM, whereas CONUT does not. Low albumin levels and increased TG, and TC in the first trimester seem to be significant in the development of GDM.
Keywords: albumingestational diabetesnutrition index
References
- Ruparelia J, Patidar R, Gosal JS, et al. American Diabetes Association Professional Practice Committee. 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes-2024. Diabetes Care. 2024; 47(Suppl 1): S20–S42.
- Guariguata L, Linnenkamp U, Beagley J, et al. Global estimates of the prevalence of hyperglycaemia in pregnancy. Diabetes Res Clin Pract. 2014; 103(2): 176–185.
- Johns EC, Denison FC, Norman JE, et al. Gestational Diabetes Mellitus: Mechanisms, Treatment, and Complications. Trends Endocrinol Metab. 2018; 29(11): 743–754.
- Cypryk K, Szymczak W, Czupryniak L, et al. Gestational diabetes mellitus - an analysis of risk factors. Endokrynol Pol. 2008; 59(5): 393–397.
- Wielgoś M, Bomba-Opoń D, Czajkowski K, et al. Towards a European Consensus on Gestational Diabetes Mellitus: A Pragmatic Guide for Diagnosis, Management, and Care. The Polish Diabetes in Pregnancy Study Group and FIGO. Ginekol Pol. 2017; 88(1): 46–49.
- Pillay J, Donovan L, Guitard S, et al. Screening for Gestational Diabetes: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2021; 326(6): 539–562.
- ElSayed NA, Aleppo G, Aroda VR, et al. 15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes-2023. Diabetes Care. 2023; 46(Suppl 1): S254–S266.
- Uemura S, Iwashita T, Ichikawa H, et al. Impact of Controlling nutritional status (CONUT) in patients with unresectable advanced pancreatic cancer receiving multi-agent chemotherapy: A single center, retrospective cohort study. Pancreatology. 2022; 22(2): 304–310.
- Ellez HI, Keskinkilic M, Semiz HS, et al. The Prognostic Nutritional Index (PNI): A New Biomarker for Determining Prognosis in Metastatic Castration-Sensitive Prostate Carcinoma. J Clin Med. 2023; 12(17).
- Kose C, Korpe B, Ibanoglu M, et al. Controlling Nutritional Status score and postmenopausal osteoporosis. Menopause. 2023; 30(5): 539–544.
- Tsai MT, Chang TH, Wu BJ. Prognostic impact of nutritional risk assessment in patients with chronic schizophrenia. Schizophr Res. 2018; 192: 137–141.
- Çiṅ tesun E, Işik E, Çelik̇ Ç, Evaluation of Prognostic Nutritional Status in Late- onset Fetal Growth Restriction | Journal of Clinical Obstetrics & Gynecology (JCOG). J Clin Obstet Gynecol. 2021; 31(1): 14–9.
- Rahnemaei FA, Pakzad R, Amirian A, et al. Effect of gestational diabetes mellitus on lipid profile: A systematic review and meta-analysis. Open Med (Wars). 2022; 17(1): 70–86.
- Metzger B, Gabbe S, Persson B, et al. International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy. Diabetes Care. 2010; 33(7): e98–e98.
- Dalmiglio C, Brilli L, Campanile M, et al. CONUT Score: A New Tool for Predicting Prognosis in Patients with Advanced Thyroid Cancer Treated with TKI. Cancers (Basel). 2022; 14(3).
- Carpenter MW. Gestational diabetes, pregnancy hypertension, and late vascular disease. Diabetes Care. 2007; 30 Suppl 2: S246–S250.
- Correa PJ, Venegas P, Palmeiro Y, et al. First trimester prediction of gestational diabetes mellitus using plasma biomarkers: a case-control study. J Perinat Med. 2019; 47(2): 161–168.
- Bukowiecka-Matusiak M, Burzynska-Pedziwiatr I, Sansone A, et al. Lipid profile changes in erythrocyte membranes of women with diagnosed GDM. PLoS One. 2018; 13(9): e0203799.
- Anjum F, Zaini R, Shami A, et al. Glycated Hemoglobin and Lipid Profile Association Among Pregnant Women in Saudi Arabian Population. International Journal of Women's Health and Reproduction Sciences. 2018; 7(2): 216–222.
- Ryckman KK, Spracklen CN, Smith CJ, et al. Maternal lipid levels during pregnancy and gestational diabetes: a systematic review and meta-analysis. BJOG. 2015; 122(5): 643–651.
- Wang J, Li Z, Lin Li. Maternal lipid profiles in women with and without gestational diabetes mellitus. Medicine (Baltimore). 2019; 98(16): e15320.
- Jiang S, Jiang J, Xu H, et al. Maternal dyslipidemia during pregnancy may increase the risk of preterm birth: A meta-analysis. Taiwan J Obstet Gynecol. 2017; 56(1): 9–15.
- Abbasi A, Bakker SJL, Corpeleijn E, et al. Liver function tests and risk prediction of incident type 2 diabetes: evaluation in two independent cohorts. PLoS One. 2012; 7(12): e51496.
- Stranges S, Rafalson LB, Dmochowski J, et al. Additional contribution of emerging risk factors to the prediction of the risk of type 2 diabetes: evidence from the Western New York Study. Obesity. 2008; 16(6): 1370–1376.
- Manolis AA, Manolis TA, Melita H, et al. Low serum albumin: A neglected predictor in patients with cardiovascular disease. Eur J Intern Med. 2022; 102: 24–39.
- Bor MV, Bor P, Cevik C. Serum fructosamine and fructosamine-albumin ratio as screening tests for gestational diabetes mellitus. Arch Gynecol Obstet. 1999; 262(3-4): 105–111.
- Chume FC, Renz PB, Hernandez MK, et al. Is there a role for glycated albumin in the diagnosis of gestational diabetes mellitus? Endocrine. 2021; 72(3): 681–687.
- Chen P, Wang S, Ji J, et al. Risk factors and management of gestational diabetes. Cell Biochem Biophys. 2015; 71(2): 689–694.
- Feng Y, Jiang CD, Chang AM, et al. Interactions among insulin resistance, inflammation factors, obesity-related gene polymorphisms, environmental risk factors, and diet in the development of gestational diabetes mellitus. J Matern Fetal Neonatal Med. 2019; 32(2): 339–347.
- Rawal S, Olsen SF, Grunnet LG, et al. Gestational Diabetes Mellitus and Renal Function: A Prospective Study With 9- to 16-Year Follow-up After Pregnancy. Diabetes Care. 2018; 41(7): 1378–1384.
